ORMP
Price
$2.27
Change
-$0.02 (-0.87%)
Updated
Sep 17 closing price
Capitalization
93.9M
57 days until earnings call
XBIT
Price
$2.67
Change
-$0.02 (-0.74%)
Updated
Sep 17 closing price
Capitalization
82.01M
49 days until earnings call
Interact to see
Advertisement

ORMP vs XBIT

Header iconORMP vs XBIT Comparison
Open Charts ORMP vs XBITBanner chart's image
Oramed Pharmaceuticals
Price$2.27
Change-$0.02 (-0.87%)
Volume$34.09K
Capitalization93.9M
XBiotech
Price$2.67
Change-$0.02 (-0.74%)
Volume$65.23K
Capitalization82.01M
ORMP vs XBIT Comparison Chart in %
Loading...
ORMP
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
XBIT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ORMP vs. XBIT commentary
Sep 18, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ORMP is a Buy and XBIT is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Sep 18, 2025
Stock price -- (ORMP: $2.27 vs. XBIT: $2.64)
Brand notoriety: ORMP and XBIT are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ORMP: 43% vs. XBIT: 138%
Market capitalization -- ORMP: $93.9M vs. XBIT: $82.01M
ORMP [@Biotechnology] is valued at $93.9M. XBIT’s [@Biotechnology] market capitalization is $82.01M. The market cap for tickers in the [@Biotechnology] industry ranges from $100.34B to $0. The average market capitalization across the [@Biotechnology] industry is $1.89B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ORMP’s FA Score shows that 0 FA rating(s) are green whileXBIT’s FA Score has 1 green FA rating(s).

  • ORMP’s FA Score: 0 green, 5 red.
  • XBIT’s FA Score: 1 green, 4 red.
According to our system of comparison, ORMP is a better buy in the long-term than XBIT.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ORMP’s TA Score shows that 6 TA indicator(s) are bullish while XBIT’s TA Score has 5 bullish TA indicator(s).

  • ORMP’s TA Score: 6 bullish, 4 bearish.
  • XBIT’s TA Score: 5 bullish, 5 bearish.
According to our system of comparison, ORMP is a better buy in the short-term than XBIT.

Price Growth

ORMP (@Biotechnology) experienced а -2.79% price change this week, while XBIT (@Biotechnology) price change was -5.71% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +1.28%. For the same industry, the average monthly price growth was +6.08%, and the average quarterly price growth was +34.58%.

Reported Earning Dates

ORMP is expected to report earnings on Nov 14, 2025.

XBIT is expected to report earnings on Nov 06, 2025.

Industries' Descriptions

@Biotechnology (+1.28% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
ORMP($93.9M) has a higher market cap than XBIT($82M). ORMP YTD gains are higher at: -6.405 vs. XBIT (-33.165). ORMP has higher annual earnings (EBITDA): -22.07M vs. XBIT (-25.88M). XBIT has more cash in the bank: 153M vs. ORMP (97.9M). ORMP has less debt than XBIT: ORMP (912K) vs XBIT (10M). ORMP has higher revenues than XBIT: ORMP (2M) vs XBIT (0).
ORMPXBITORMP / XBIT
Capitalization93.9M82M115%
EBITDA-22.07M-25.88M85%
Gain YTD-6.405-33.16519%
P/E Ratio20.91N/A-
Revenue2M0-
Total Cash97.9M153M64%
Total Debt912K10M9%
FUNDAMENTALS RATINGS
ORMP vs XBIT: Fundamental Ratings
ORMP
XBIT
OUTLOOK RATING
1..100
1970
VALUATION
overvalued / fair valued / undervalued
1..100
53
Fair valued
70
Overvalued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
9595
PRICE GROWTH RATING
1..100
5365
P/E GROWTH RATING
1..100
437
SEASONALITY SCORE
1..100
90n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

ORMP's Valuation (53) in the Pharmaceuticals Other industry is in the same range as XBIT (70) in the Biotechnology industry. This means that ORMP’s stock grew similarly to XBIT’s over the last 12 months.

ORMP's Profit vs Risk Rating (100) in the Pharmaceuticals Other industry is in the same range as XBIT (100) in the Biotechnology industry. This means that ORMP’s stock grew similarly to XBIT’s over the last 12 months.

ORMP's SMR Rating (95) in the Pharmaceuticals Other industry is in the same range as XBIT (95) in the Biotechnology industry. This means that ORMP’s stock grew similarly to XBIT’s over the last 12 months.

ORMP's Price Growth Rating (53) in the Pharmaceuticals Other industry is in the same range as XBIT (65) in the Biotechnology industry. This means that ORMP’s stock grew similarly to XBIT’s over the last 12 months.

XBIT's P/E Growth Rating (7) in the Biotechnology industry is somewhat better than the same rating for ORMP (43) in the Pharmaceuticals Other industry. This means that XBIT’s stock grew somewhat faster than ORMP’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
ORMPXBIT
RSI
ODDS (%)
Bearish Trend 1 day ago
88%
Bullish Trend 1 day ago
89%
Stochastic
ODDS (%)
Bearish Trend 1 day ago
82%
Bullish Trend 1 day ago
75%
Momentum
ODDS (%)
Bullish Trend 1 day ago
87%
Bearish Trend 1 day ago
86%
MACD
ODDS (%)
Bullish Trend 1 day ago
76%
Bearish Trend 1 day ago
80%
TrendWeek
ODDS (%)
Bearish Trend 1 day ago
81%
Bearish Trend 1 day ago
84%
TrendMonth
ODDS (%)
Bullish Trend 1 day ago
82%
Bearish Trend 1 day ago
85%
Advances
ODDS (%)
Bullish Trend 7 days ago
82%
Bullish Trend 7 days ago
65%
Declines
ODDS (%)
Bearish Trend 1 day ago
81%
Bearish Trend 1 day ago
84%
BollingerBands
ODDS (%)
Bearish Trend 1 day ago
77%
Bullish Trend 1 day ago
82%
Aroon
ODDS (%)
Bullish Trend 1 day ago
83%
Bullish Trend 1 day ago
71%
View a ticker or compare two or three
Interact to see
Advertisement
ORMP
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
XBIT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
DCHRF0.04N/A
N/A
DISCOVERY HARBOUR RES CORP.
PRBZF67.38N/A
N/A
Premium Brands Holding Corp.
STBMF0.29N/A
N/A
St. Barbara Ltd.
CLRCF12.10N/A
N/A
ClimateRock
KUBTY62.42-0.72
-1.13%
Kubota Corp.

ORMP and

Correlation & Price change

A.I.dvisor indicates that over the last year, ORMP has been loosely correlated with BTAI. These tickers have moved in lockstep 44% of the time. This A.I.-generated data suggests there is some statistical probability that if ORMP jumps, then BTAI could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ORMP
1D Price
Change %
ORMP100%
-1.09%
BTAI - ORMP
44%
Loosely correlated
-3.18%
INO - ORMP
44%
Loosely correlated
-4.39%
MBIO - ORMP
44%
Loosely correlated
+3.80%
ZNTL - ORMP
43%
Loosely correlated
+0.70%
RVMD - ORMP
42%
Loosely correlated
-2.01%
More